Obesity is an emerging independent risk factor for susceptibility to and severity of
coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a
challenge for all participants in the healthcare system. At the beginning of the pandemic …

Objective The aim of this study was to evaluate the efficacy of anakinra in patients who were
admitted to hospital for severe COVID-19 pneumonia requiring oxygen therapy. Methods A …

The outbreak of COVID-19 reminds us that the emerging and reemerging respiratory virus
infections pose a continuing threat to human life. Cytokine storm syndromes of viral origin …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can give rise to
different clinical manifestations that are directly related to viral tissue damage or indirectly …

Abstract Purpose: COVID-19, a novel infection, presented with several complications,
including socioeconomical and reproductive health challenges such as erectile dysfunction …

Rationale Factors associated with long-term sequelae emerging after the acute phase of
COVID-19 (so called “long COVID”) are unclear. Here, we aimed to identify risk factors for …

Whether solid organ transplant (SOT) recipients are at increased risk of poor outcomes due
to COVID‐19 in comparison to the general population remains uncertain. In this study, we …

Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid, obtained from the
plant Glycyrrhiza glabra, have numerous pharmacological activities, such as anti …

The suppressor of cytokine signaling (SOCS) family of intracellular checkpoint inhibitors has
received little recognition compared to other checkpoint inhibitors. Two members of this …